Log In Sign up
The largest database of trusted experimental protocols

P38δ sirnas

Manufactured by Thermo Fisher Scientific
Visit Supplier

P38δ siRNAs are a type of small interfering RNA (siRNA) that target the p38δ isoform of the p38 mitogen-activated protein kinase (MAPK) family. They are designed to specifically reduce the expression of the p38δ protein within cells.

Automatically generated - may contain errors

Lab products found in correlation

Sirna2, by Thermo Fisher Scientific (2 mentions) Allstar sirna, by Qiagen (2 mentions) Opti mem medium, by Thermo Fisher Scientific (2 mentions) Lipofectamine rnaimax reagent, by Thermo Fisher Scientific (2 mentions)

2 protocols using p38δ sirnas

1

Silencing p38δ in Breast Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lipofectamine RNAiMAX reagent, Opti-MEM medium and p38δ siRNAs (siRNA-#1: Cat No142319 and siRNA-#2: Cat No 142320) were obtained from Invitrogen. p38δ siRNAs or AllStar siRNA (Qiagen) as a negative control were transfected into MCF-7 or MDA-MB-231 cells (20 nM) according to the manufacturer’s protocol. Forty-eight hours after transfection, cells were used for the indicated experiments.
Wada M., Canals D., Adada M., Coant N., Salama M.F., Helke K.L., Arthur J.S., Shroyer K.R., Kitatani K., Obeid L.M, & Hannun Y.A. (2017). P38 delta MAPK promotes breast cancer progression and lung metastasis by enhancing cell proliferation and cell detachment. Oncogene, 36(47), 6649-6657.
+ Open protocol
+ Expand
2

Silencing p38δ in Breast Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lipofectamine RNAiMAX reagent, Opti-MEM medium and p38δ siRNAs (siRNA-#1: Cat No142319 and siRNA-#2: Cat No 142320) were obtained from Invitrogen. p38δ siRNAs or AllStar siRNA (Qiagen) as a negative control were transfected into MCF-7 or MDA-MB-231 cells (20 nM) according to the manufacturer’s protocol. Forty-eight hours after transfection, cells were used for the indicated experiments.
Wada M., Canals D., Adada M., Coant N., Salama M.F., Helke K.L., Arthur J.S., Shroyer K.R., Kitatani K., Obeid L.M, & Hannun Y.A. (2017). P38 delta MAPK promotes breast cancer progression and lung metastasis by enhancing cell proliferation and cell detachment. Oncogene, 36(47), 6649-6657.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!